Brian Guan-Chyun Liu - 25 Jun 2026 Form 4 Insider Report for CG Oncology, Inc. (CGON)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
29 Jun 2026, 17:26:56 UTC
Prior SEC filing
05 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brian Guan-Chyun Liu

Key filing fact

Brian Guan-Chyun Liu filed Form 4 for CG Oncology, Inc. (CGON) on 29 Jun 2026.

Key facts

  • This page summarizes Brian Guan-Chyun Liu's Form 4 filing for CG Oncology, Inc. (CGON).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 29 Jun 2026, 17:26.

Change

  • Previous filing in this sequence was filed on 05 Jun 2026.
  • Current net transaction value: +$24,814,454.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002007835 Primary reporting owner

Liu Brian Guan-Chyun

Relationship
Director
Address
C/O CG ONCOLOGY, INC., 400 SPECTRUM CENTER DRIVE, SUITE 2040, IRVINE
Signature
/s/ Brian Guan-Chyun Liu
Signature date
29 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CGON transaction

Common Stock

Purchase

Transaction value
$24,814,454
Shares
+371,085
Change %
+24%
Price
$66.87
Shares after
1,886,236
Date
25 Jun 2026
Ownership
By Seven Fleet Partners LP
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The Reporting Person, as the managing member of Seven Fleet Advisors, LLC, the investment manager of Seven Fleet Partners, LP, may be deemed to beneficially own the shares of Common Stock held by Seven Fleet Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .